Myeloid derived suppressor cells (MDSC) correlate with inflammatory biomarkers in metastatic urothelial carcinoma (mUC).

MLA

Grivas, Petros, et al. “Myeloid Derived Suppressor Cells (MDSC) Correlate with Inflammatory Biomarkers in Metastatic Urothelial Carcinoma (MUC).” Urologic Oncology, vol. 35, no. 10, Oct. 2017, pp. 611–12. EBSCOhost, https://doi.org/10.1016/j.urolonc.2017.06.014.

APA

Grivas, P., Diaz-Montero, C. M., Rayman, P. A., Elson, P., Haywood, S., Sub Kim, J., Pavicic, P. G., Finke, J., Rini, B. I., Stephenson, A. J., Lamenza, M., Dann, P., Schach, K., Devonshire, S., Ko, J. S., Farouk Fergany, A., Ernstoff, M. S., Hoimes, C. J., Garcia, J. A., & Chaim Ornstein, M. (2017). Myeloid derived suppressor cells (MDSC) correlate with inflammatory biomarkers in metastatic urothelial carcinoma (mUC). Urologic Oncology, 35(10), 611–612. https://doi.org/10.1016/j.urolonc.2017.06.014

Chicago

Grivas, Petros, C. Marcela Diaz-Montero, Patricia A. Rayman, Paul Elson, Samuel Haywood, Jin Sub Kim, Paul G Pavicic, et al. 2017. “Myeloid Derived Suppressor Cells (MDSC) Correlate with Inflammatory Biomarkers in Metastatic Urothelial Carcinoma (MUC).” Urologic Oncology 35 (10): 611–12. doi:10.1016/j.urolonc.2017.06.014.